Chemomab Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMMB and other ETFs, options, and stocks.About CMMB
Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
CEOAdi Mor
CEOAdi Mor
Employees16
Employees16
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2011
Founded2011
Employees16
Employees16
CMMB Key Statistics
Market cap13.71M
Market cap13.71M
Price-Earnings ratio-1.13
Price-Earnings ratio-1.13
Dividend yield—
Dividend yield—
Average volume132.84K
Average volume132.84K
High today$2.82
High today$2.82
Low today$2.60
Low today$2.60
Open price$2.75
Open price$2.75
Volume56.20K
Volume56.20K
52 Week high$9.84
52 Week high$9.84
52 Week low$2.39
52 Week low$2.39
Stock Snapshot
Chemomab Therapeutics(CMMB) stock is priced at $2.60, giving the company a market capitalization of 13.71M. It carries a P/E multiple of -1.13.
On 2025-11-05, Chemomab Therapeutics(CMMB) stock traded between a low of $2.60 and a high of $2.82. Shares are currently priced at $2.60, which is 0.0% above the low and -7.8% below the high.
Chemomab Therapeutics(CMMB) shares are trading with a volume of 56.2K, against a daily average of 132.84K.
In the last year, Chemomab Therapeutics(CMMB) shares hit a 52-week high of $9.84 and a 52-week low of $2.39.
In the last year, Chemomab Therapeutics(CMMB) shares hit a 52-week high of $9.84 and a 52-week low of $2.39.